Zeer SOPHiA GENETICS / intent / sophia-genetics

SOPHiA GENETICS

201-500 employees·Lausanne, Vaud, Switzerland·sophiagenetics.com

Observed, not inferred · updated weekly

Buying intent

32 tracked signals | Top 15 topics are below | Marketing and Sales are carrying most of it.

24signals · 30 days
23topics tracked
40%attributed to a team

Attention by team

LinkedIn activity, by team

Where SOPHiA GENETICS's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.

Artificial Intelligence
Hiring
Leadership Development
Precision Medicine
MBA Programs
AI Agent Software
Marketing
Medium67% of team Marketing to Artificial Intelligence: Medium, 67% of this team's signals
Marketing to Hiring: no signal
Marketing to Leadership Development: no signal
Marketing to Precision Medicine: no signal
Marketing to MBA Programs: no signal
Low33% of team Marketing to AI Agent Software: Low, 33% of this team's signals
Sales
Sales to Artificial Intelligence: no signal
Sales to Hiring: no signal
Sales to Leadership Development: no signal
Low50% of team Sales to Precision Medicine: Low, 50% of this team's signals
Low50% of team Sales to MBA Programs: Low, 50% of this team's signals
Sales to AI Agent Software: no signal
Operations
Operations to Artificial Intelligence: no signal
Operations to Hiring: no signal
Low100% of team Operations to Leadership Development: Low, 100% of this team's signals
Operations to Precision Medicine: no signal
Operations to MBA Programs: no signal
Operations to AI Agent Software: no signal
Others
High33% of team Others to Artificial Intelligence: High, 33% of this team's signals
High44% of team Others to Hiring: High, 44% of this team's signals
Low11% of team Others to Leadership Development: Low, 11% of this team's signals
Low11% of team Others to Precision Medicine: Low, 11% of this team's signals
Others to MBA Programs: no signal
Others to AI Agent Software: no signal
LowMediumHigh·  banded against the busiest pairing on this page

Topics being researched

30-day window

Every tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.

Artificial Intelligence
LinkedIn
High volume
92%
last
12d ago
Hiring
LinkedIn
High volume
94%
last
13d ago
Leadership Development
LinkedIn
Medium volume
95%
last
17d ago
Precision Medicine
LinkedIn
Medium volume
96%
last
13d ago
MBA Programs
LinkedIn
Low volume
92%
last
31d ago
AI Agent Software
LinkedIn
Low volume
98%
last
29d ago
Agentic AI System
LinkedIn
Low volume
98%
last
29d ago
Actionable Insights
LinkedIn
Low volume
82%
last
12d ago
Comparative Analysis
LinkedIn
Low volume
98%
last
10d ago
Digital Health
LinkedIn
Low volume
98%
last
18d ago
Career Development
LinkedIn
Low volume
98%
last
10d ago
Business Case
LinkedIn
Low volume
98%
last
13d ago
Brand Voice
LinkedIn
Low volume
98%
last
25d ago
C-suite
LinkedIn
Low volume
96%
last
13d ago
Data Integration
LinkedIn
Low volume
98%
last
23d ago

Need intent for a specific topic or industry?

We track the full taxonomy across every account in the graph — including themes not shown on this page.

Talk to us

Who's active at SOPHiA GENETICS

verified title on file

Titles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.

Others6 active
researching Actionable Insights
in
researching C-suite
in
Executiveresearching Business Analyst
in
researching Career Development
in
researching Open Source
in
Marketing1 active
Senior ICresearching Artificial Intelligence
in
Operations1 active
Directorresearching Leadership Development
in

Primary products / business lines

LinkedIn company profile

SOPHiA GENETICS was founded in 2011 by biologists who had a vision to create a technology that could make a positive and lasting impact on the world, using data for good. We’ve built a revolutionary technology platform, SOPHiA DDM™, that rapidly distills complex data into actionable insights, enabling clinicians, researchers, and biopharma to reshape the way that we diagnose and treat cancer an

Top accounts researching SOPHiA GENETICS

names withheld on the public page

These are companies whose own people brought up SOPHiA GENETICS unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.

151,426 companies · 839,012 people are researching Artificial Intelligence

SOPHiA GENETICS's own team shows 5 signals on this topic. No one outside SOPHiA GENETICS has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.

  • Hiring75,708 cos · 411,263 people
  • Leadership Development24,131 cos · 93,859 people
Sign up to see which companies →

Buyer profile

company size · seniority

Company size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.

Unlock the buyer profile

Company-size breakdown and buyer seniority mix for accounts researching SOPHiA GENETICS.

Company size breakdown
Buyer seniority mix

Sign up to learn more

Create an account to explore buyer insights as they become available.

Sign up to learn more →

Buying committee functions

Employee job titles (LinkedIn)

Sales — 4 people; Marketing — 1 person; Leadership — 1 person

What's been said

public posts mentioning SOPHiA GENETICS

Up to 9 public excerpts naming SOPHiA GENETICS from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.

LinkedIn

Blood-based comprehensive genomic profiling tests using circulating tumor DNA have been approved in Japan , but that’s just the starting line. Timing of use, reimbursement pathways, and clinical integration remain genuinely complex questions. The real strategic imperative is building testing capacity within Japan itself — moving away from overseas laboratory dependency. Getting turnaround times competitive, reimbursement aligned, and clinical workflows embedded locally is what actually matters for patients. Join our talk with Philippe Menu , SOPHiA GENETICS , and Michel Mommejat , A.D.A.M. Innovations (formerly Genesis Healthcare – GeneLife) as we explore how to translate the global vision of liquid biopsy into the local realities that matter in Japan. If you’re attending, let’s connect. Always better to share insights over coffee than slides.

May 2026

About this data. SOPHiA GENETICS (sophiagenetics.com). Department attribution is 40%; remaining activity is grouped under Others. Updated 2026-10-03T14:00:03.490Z.

Not yet computedPer-team narrative summaries